Maryland Parkinson's Disease and Movement Disorders Center

Clinical Trials

Clinical trials are studies designed to find new and better ways to treat patients with Parkinson's disease and other movement disorders. The physicians at the Maryland Parkinson's Disease and Movement Disorders Center are currently conducting the clinical trials listed below.

Studies open frequently. If interested in the latest information regarding our studies, please call Kelly Dustin, RN, MS, CCRC at 410-328-7817.

Clinical Trial Detail - NET PD LS-1 Study
Definition:	The NIH is sponsoring a study of the impact of creatine, an investigational drug, on slowing the clinical decline in patients with PD. All qualified participants will receive the study medication as well as study-related health assessments by a licensed neurologist.
Investigator:	Lisa M. Shulman, MD
Eligibility:	Participants must: Have been diagnosed with PD within the last 5 years Have been using medication to treat the symptoms for more than 90 days bot less than 2 years. Participants must not: Have unstable medical conditions Have an intolerability to creatine
Contact:	For more information or to inquire about participating, call Kelly Dustin at 410-328-7817.
Clinical Trial Detail - Exercise Study: Click here for more information.
Definition:	The Michael J. Fox Foundation for Parkinson's Research has funded this study to investigate the benefits of exercise for fitness, walking, and balance in people with Parkinson's disease.
Investigator:	Lisa Shulman, M.D.
Eligibility:	Participants must be diagnosed with Parkinson's disease and be able to walk.
Contact:	For more information or to inquire about participating, call Terra Hill at 443-827-0677.
Clinical Trial Detail - Study of Antidepressants in Parkinson's Disease (SAD PD)
Definition:	This study is important because researchers estimate that 40-50% of PD patients will experience depression during the course of their disease, yet there have been no large scale research studies examining the effects of antidepressants on patients with Parkinson's disease.
Investigator:	Lisa Shulman, MD
Eligibility:	In order to participate in SAD-PD, patients must be: over 30 years old, diagnosed with Parkinson's disease, experiencing symptoms of depression (such as sadness, decreased energy, or problems sleeping)
Contact:	For more information or to inquire about participating, call Kelly Dustin at 410-328-7817.
Clinical Trial Detail - PROGENI for Parkinson's disease
Definition:	Parkinson's Research: The Organized Genetics Initiative; A genetic observational study of siblings with Parkinson's disease
Investigator:	Lisa Shulman, M.D.
Eligibility:	Participants must be siblings with Parkinson's disease.
Contact:	For more information or to inquire about participating, call Kelly Dustin at 410-328-7817.

This page was last updated on: March 27, 2008.

For more information about the University Physicians Consultation and Referral Service, please call 1-800-492-5538 (patients) or 1-800-373-4111 (physicians).